Republican Donald Trump, a far-right demagogue who campaigned on a slew of bigoted, xenophobic policies, has won the 2016 presidential election in a shocking victory few people predicted. What was not ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Taysha Gene Therapies yesterday and set a price target of $13.00. The company’s shares closed yesterday at $4.01. Kluska covers the ...

In a report released today, Siti Panigrahi from Mizuho Securities reiterated a Buy rating on NICE, with a price target of $150.00. Claim 60% off TipRanks Premium for the data-backed insights and ...

In a report released today, Catharine Trebnick from Rosenblatt Securities reiterated a Buy rating on NICE, with a price target of $175.00. Claim 60% off TipRanks Premium for the data-backed insights ...

In a report released today, from Goldman Sachs maintained a Hold rating on Arrowhead Pharmaceuticals, with a price target of $48.00. Claim 60% off TipRanks Premium for the data-backed insights and ...

In a report released today, Nitin Kumar CFA from Mizuho Securities reiterated a Buy rating on EQT, with a price target of $60.00. Claim 60% off TipRanks Premium for the data-backed insights and ...

In a report released on November 19, Anupam Rama from J.P. Morgan maintained a Buy rating on Nuvalent, with a price target of $147.00. The company’s shares closed yesterday at $107.13. Claim 60% off ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Canadian figure skaters are in position to reach the podium in every discipline following strong short programs Friday at the 2025 Finlandia Trophy. Piper Gilles and Paul Poirier sit second after ...

In a report released today, Elyse Greenspan from Wells Fargo maintained a Hold rating on Brighthouse Financial, with a price target of $53.00. The company’s shares opened today at $48.48. Take ...